+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology

Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology

Frontiers in Immunology 10: 348

Breast cancer is characterized by cellular and molecular heterogeneity. Several molecular events are involved in controlling malignant cell process. In this sense, the importance of studying multiple cell alterations in this pathology is overriding. A well-identified fact on immune response is that it can vary depend on sex. Steroid hormones and their receptors may regulate different functions and the responses of several subpopulations of the immune system. Few reports are focused on the function of estrogen receptors (ERs) on immune cells and their roles in different breast cancer subtypes. Thus, the aim of this review is to investigate the immune infiltrating tumor microenvironment and prognosis conferred by it in different breast cancer subtypes, discuss the current knowledge and point out the roles of estrogens and its receptors on the infiltrating immune cells, as well as to identify how different immune subsets are modulated after anti-hormonal treatments in breast cancer patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 066598643

Download citation: RISBibTeXText

PMID: 30881360

DOI: 10.3389/fimmu.2019.00348

Related references

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. Plos one 4(11): E7965, 2009

Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Research 5(1): 31-36, 2003

A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell 174(6): 1373-1387.E19, 2018

Anti-tumor effects of DNA vaccine targeting human fibroblast activation protein α by producing specific immune responses and altering tumor microenvironment in the 4T1 murine breast cancer model. Cancer Immunology ImmunoTherapy 65(5): 613-624, 2016

Tumor microenvironment in breast cancer metastasis: direct tissue protein profiling of tumor-associated stroma from invasive breast cancer patients with versus without axillary lymph node metastasis. 2007

Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment. Analyst 139(5): 1044-1056, 2014

Didymin reverses phthalate ester-associated breast cancer aggravation in the breast cancer tumor microenvironment. Oncology Letters 11(2): 1035-1042, 2016

'Tu quoque Brute fili mihi!' (Julius Caesar, Ides of March, 44 BC): role of tumor microenvironment and immune system in breast cancer progression. Current Opinion in Oncology 26(6): 543-544, 2014

Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Critical Reviews in Oncology/Hematology 51(1): 55-67, 2004

The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer. Journal of Histochemistry and Cytochemistry 65(6): 335-346, 2017

Breast cancer bone metastases: combination therapy targeting cancer cells and the tumor microenvironment. Cancer Biology and Therapy 9(7): 551-553, 2010

Breast cancer bone metastases: Combination therapy targeting cancer cells and the tumor microenvironment. Cancer Biology & Therapy 9(7): 551-553, 2010

Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Reviews 37(4): 577-597, 2018

Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine. Journal of Translational Medicine 12: 294, 2014

The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells. Breast Cancer Research 20(1): 16, 2018